Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

5.1K
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
5.1K
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

961
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
961

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance measures for endoscopic ultrasound: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative - Update 2025.

Endoscopy·2025
Same author

EUS Guided FNA Cell Block Cytology and Intraoperative Squash Cytology in the Diagnostic Approach of Unfamiliar Malignant Neoplastic Disorders.

Acta medica (Hradec Kralove)·2025
Same author

Results of the COLDWATER randomized controlled trial: enhanced performance of underwater cold snare polypectomy for colorectal polyps 5-10 mm, independent of endoscopist experience.

Annals of gastroenterology·2024
Same author

Bariatric Nutritional Intervention in Obese Patients with Compensated Liver Cirrhosis: A Four-Year Prospective Study.

Digestive diseases and sciences·2024
Same author

Curriculum for diagnostic endoscopic ultrasound training in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement.

Endoscopy·2023
Same author

The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review.

European journal of clinical pharmacology·2023

Related Experiment Video

Updated: Mar 16, 2026

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

8.5K

All-cause mortality after ERCP.

Evangelos Kalaitzakis1

  • 1Department of Clinical Sciences, University of Lund, Lund, Sweden.

Endoscopy
|August 6, 2016
PubMed
Summary

This study validated an English model for 30-day mortality after endoscopic retrograde cholangiopancreatography (ERCP) and developed a new model for up to 12-month mortality, finding cancer and underlying conditions are key predictors.

Area of Science:

  • Gastroenterology
  • Medical Statistics
  • Public Health

Background:

  • Endoscopic retrograde cholangiopancreatography (ERCP) is a common procedure with associated mortality risks.
  • Existing models for predicting short-term mortality post-ERCP require external validation.
  • Limited data exists on long-term mortality following ERCP.

Purpose of the Study:

  • To externally validate an existing English model for predicting 30-day mortality after ERCP.
  • To develop and validate a new prediction model for mortality up to 12 months post-ERCP.
  • To identify predictors of both short-term and medium-term mortality.

Main Methods:

  • Utilized Swedish Hospital Discharge Registry data for 16,478 patients undergoing their first ERCP.
  • Linked ERCP data with the Swedish Death Registry for mortality tracking.

More Related Videos

An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function
09:40

An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function

Published on: April 17, 2020

15.4K

Related Experiment Videos

Last Updated: Mar 16, 2026

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

8.5K
An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function
09:40

An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function

Published on: April 17, 2020

15.4K
  • Employed Cox proportional hazards analysis to identify mortality predictors and develop prediction models.

    • Main Results:

    • The English model slightly overpredicted 30-day mortality but was accurate after recalibration (c-statistic=0.82).
    • Mortality increased from 5% at 30 days to 11.9% at 3 months post-ERCP.
    • Key predictors for up to 12-month mortality included emergency admission, cancer, co-morbidity, gallstone diagnosis, and age (c-statistic=0.86–0.88).

    Conclusions:

    • Mortality post-ERCP doubles between 30 days and 3 months, primarily due to underlying conditions like cancer, not ERCP complications.
    • The previously developed 30-day mortality prediction model was successfully externally validated.
    • A novel, accurate model for predicting mortality up to 12 months post-ERCP was developed.